(2026). Use of the GSK MenACWY-CRM/MenB-4C Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025. MMWR Morbidity and Mortality Weekly Report.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Use of the GSK MenACWY-CRM/MenB-4C Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025."
MMWR Morbidity and Mortality Weekly Report 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Use of the GSK MenACWY-CRM/MenB-4C Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025."
MMWR Morbidity and Mortality Weekly Report, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.